• 1. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 2. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 3. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 4. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 5. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813

2-Pyrrolidinemethanol, 4-hydroxy-, (2R,4R)- (CAS No. 343633-22-7): A Comprehensive Overview

2-Pyrrolidinemethanol, 4-hydroxy-, (2R,4R)- (CAS No. 343633-22-7) is a chiral compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This compound belongs to the class of pyrrolidines, which are nitrogen-containing heterocyclic compounds with a wide range of biological activities. The (2R,4R) stereochemistry of this compound is crucial for its biological activity and selectivity.

The chemical structure of 2-Pyrrolidinemethanol, 4-hydroxy-, (2R,4R)- consists of a pyrrolidine ring with a hydroxyl group at the 4-position and a methanol group at the 1-position. The presence of these functional groups, along with the specific stereochemistry, imparts unique physical and chemical properties to the molecule. These properties make it an attractive candidate for various applications in drug discovery and development.

Recent studies have highlighted the potential of 2-Pyrrolidinemethanol, 4-hydroxy-, (2R,4R)- in several therapeutic areas. One notable application is in the treatment of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Research has shown that this compound can modulate key signaling pathways involved in neuronal survival and function. For instance, it has been found to inhibit the aggregation of amyloid-beta peptides, which are implicated in the pathogenesis of Alzheimer's disease.

In addition to its neuroprotective effects, 2-Pyrrolidinemethanol, 4-hydroxy-, (2R,4R)- has also demonstrated anti-inflammatory properties. In vitro studies have shown that it can reduce the production of pro-inflammatory cytokines such as TNF-α and IL-6 in activated immune cells. This property makes it a promising candidate for the treatment of inflammatory disorders such as rheumatoid arthritis and multiple sclerosis.

The pharmacokinetic profile of 2-Pyrrolidinemethanol, 4-hydroxy-, (2R,4R)- has been extensively studied to understand its behavior in biological systems. It has been found to have good oral bioavailability and a favorable distribution profile, allowing it to reach target tissues effectively. Furthermore, its metabolic stability ensures that it remains active for an extended period, enhancing its therapeutic potential.

Clinical trials are currently underway to evaluate the safety and efficacy of 2-Pyrrolidinemethanol, 4-hydroxy-, (2R,4R)- in various indications. Preliminary results from phase I trials have shown that the compound is well-tolerated by patients with minimal side effects. These findings have paved the way for further clinical development and potential commercialization.

The synthesis of 2-Pyrrolidinemethanol, 4-hydroxy-, (2R,4R)- involves several steps that require precise control over stereochemistry. Common synthetic routes include asymmetric synthesis using chiral catalysts or chiral auxiliaries to ensure the formation of the desired enantiomer. The ability to synthesize this compound on a large scale with high purity and yield is crucial for its commercial viability.

In conclusion, 2-Pyrrolidinemethanol, 4-hydroxy-, (2R,4R)- (CAS No. 343633-22-7) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique structural features and biological activities make it an attractive candidate for further investigation and development. Ongoing research and clinical trials will continue to uncover new insights into its therapeutic potential and contribute to advancements in drug discovery.

• 105015-44-9((2S,5S)-Bishydroxymethyl-(3R,4R)-bishydroxypyrrolidine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)